Clinical Trial Update: Evaluate the Effect of Tirazamine on Primary Liver Cancer. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating tirazamine for hepatocellular carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Tirazamine (tirazamine)

Snippet

Sponsor: Zhejiang Raygene Pharmaceuticals Co., Ltd | Conditions: Hepato Cellular Carcinoma (HCC) | Phase 1, Phase 2 | Status: TERMINATED